Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000012

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 27, 2017
Accepted (ET)
Mar 2, 2017 · 7:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 27, 2017P500$0.0382A19,696,749D
Common StockJan 27, 2017P200$0.0374A19,696,949D
Common StockJan 27, 2017P300$0.0378A19,697,249D
Common StockJan 27, 2017P1,000$0.0382A19,698,249D
Common StockJan 30, 2017P200$0.039A19,698,449D
Common StockJan 30, 2017P200$0.0388A19,698,649D
Common StockJan 30, 2017P500$0.0371A19,699,149D
Common StockJan 30, 2017P500$0.0344A19,699,649D
Common StockJan 30, 2017P500$0.0369A19,700,149D
Common StockJan 30, 2017P200$0.0358A19,700,349D
Common StockJan 30, 2017P1,000$0.035A19,701,349D
Common StockJan 30, 2017P1,000$0.0322A19,702,349D
Common StockJan 30, 2017P1,000$0.0325A19,703,349D
Common StockJan 31, 2017P1,000$0.0368A19,704,349D
Common StockFeb 1, 2017P1,000$0.0329A19,705,349D
Common StockFeb 1, 2017P200$0.034A19,705,549D
Common StockFeb 1, 2017P500$0.034A19,706,049D
Common StockFeb 1, 2017P1,000$0.0334A19,707,049D
Common StockFeb 1, 2017P200$0.0335A19,707,249D
Common StockFeb 1, 2017P200$0.03A19,707,449D
Common StockFeb 1, 2017P1,000$0.0336A19,708,449D
Common StockFeb 1, 2017P500$0.0337A19,708,949D
Common StockFeb 2, 2017P200$0.0339A19,709,149D
Common StockFeb 2, 2017P1,000$0.029A19,710,149D
Common StockFeb 2, 2017P1,000$0.029A19,711,149D
Common StockFeb 2, 2017P200$0.024A19,711,349D
Common StockFeb 2, 2017P500$0.025A19,711,849D
Common StockFeb 2, 2017P100$0.025A19,711,949D
Common StockFeb 3, 2017P200$0.029A19,712,149D
Common StockFeb 3, 2017P1,000$0.026A19,713,149D

Table II — derivative securities

No Table II lines on this filing.